Novo Nordisk A S 6-K Filing
Ticker: NVO · Form: 6-K · Filed: Apr 7, 2026 · CIK: 0000353278
Sentiment: neutral
Filing Stats: 620 words · 2 min read · ~2 pages · Grade level 10.1 · Accepted 2026-04-07 07:28:44
Filing Documents
- f6k_040726.htm (6-K) — 21KB
- logo.jpg (GRAPHIC) — 76KB
- ca.jpg (GRAPHIC) — 24KB
- 0001171843-26-002279.txt ( ) — 160KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf of the undersigned, thereunto duly authorized. Date: April 7, 2026 NOVO NORDISK A/S Maziar Mike Doustdar Chief Executive Officer